FloBio
PrivateLast Round
Grant
May 1, 2022
Total Funding Raised
$1.05M
Company Overview
FloBio is a healthcare company that develops a novel fluidic-based point-of-care diagnostic platform for assessing blood clotting and thrombotic risk in emergency and critical care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FloBio Comparables
Compare FloBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stasys Medical Corporation | 86% | |
| Sienco, Inc. | 83% | |
| Perosphere Technologies Inc. | 83% |
FloBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2022 | ||||
| Seed | Jan 19, 2021 | ||||
| Grant | Nov 1, 2020 | ||||
| Grant | Aug 1, 2020 | ||||
| Grant | Sep 1, 2019 | ||||
Grant | May 2, 2019 |
FloBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Seed |
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Pennsylvania Pediatric Medical Device Consortium | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 198% MoM, reaching 2K.
- Apr 5, 2026
Monthly visitors grew 47% MoM.
FloBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FloBio's valuation, stock price, and market status.
Is FloBio a public or private company?
FloBio is a private company.
What is the current stock price of FloBio?
FloBio is a private company with no public stock price. No recent secondary market data is available.
How much is FloBio worth (valuation)?
Valuation information for FloBio is not publicly available.
Can I buy FloBio stock?
FloBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FloBio's last funding round?
FloBio's most recent funding round was Grant on May 1, 2022.
Who are the main investors in FloBio?
Key investors in FloBio include Benjamin Franklin Technology Partners, NIH RADx, National Heart, Lung, and Blood Institute, Pennsylvania Pediatric Medical Device Consortium, National Science Foundation.
Will FloBio IPO soon?
No public IPO plans have been announced for FloBio.
How can I track FloBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FloBio's secondary market activity and sign up for updates.